Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Assets (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Return on Assets for 4 consecutive years, with 0.45% as the latest value for Q2 2025.

  • On a quarterly basis, Return on Assets changed N/A to 0.45% in Q2 2025 year-over-year; TTM through Jun 2025 was 0.45%, a N/A change, with the full-year FY2024 number at 0.5%, down 13.0% from a year prior.
  • Return on Assets was 0.45% for Q2 2025 at Centessa Pharmaceuticals, down from 0.41% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.32% in Q3 2024 to a low of 0.47% in Q4 2022.
  • A 4-year average of 0.41% and a median of 0.41% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: increased 6bps in 2023, then rose 1bps in 2024.
  • Centessa Pharmaceuticals' Return on Assets stood at 0.47% in 2022, then grew by 12bps to 0.41% in 2023, then rose by 3bps to 0.4% in 2024, then fell by -14bps to 0.45% in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Return on Assets are 0.45% (Q2 2025), 0.41% (Q1 2025), and 0.4% (Q4 2024).